Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Compounding is essential for effective wealth building. Discover why it matters and how to incorporate it into your financial plans.
20,792 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Coinbase stock stalls $200 after a 14% surge, with traders watching volume and regulatory headlines for the next move...
A notable fund exited its position in a medical device stock, locking in gains as the shares slipped over the past ye...
A prompt-driven AI nicknamed Grok projects sharp gains for XRP, Bitcoin, and Ethereum by late 2026, even as oil-drive...
Arizona lawmakers move two bills designed to curb local HOA and contractor licensing mandates, aiming to lower costs ...
Stocks jumped after President Trump signaled possible de-escalation with Iran, fueling a risk-on rally. Yet analysts ...
A sharp one-day drop can leave investors anxious and markets buzzing. This guide breaks down the drivers behind super...
A high-profile legal clash over concert logistics shines a light on how money moves in the music business. This artic...
Two major AI infrastructure players appear attractively priced as heavy investment in AI chips and automation presses...
A KRW-backed stablecoin and offshore perpetual futures contract launch in April 2026, signaling Wall Street’s push to...
Tether has hired its first full independent audit from a Big Four firm, marking a major step toward transparency afte...
Morgan Stanley boosted its price target on Planet Labs to $35, citing rising defense and intelligence demand and a ro...